相关实验视频
Updated: Jun 11, 2025
15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
9.6K
长期神经-COVID-19:当前的机制观点和治疗前景
Anny Slama Schwok1, Julien Henri2
1Sorbonne Université, INSERM U938, Biology and Cancer Therapeutics, Centre de Recherche Saint Antoine, Saint Antoine Hospital, 75231 Paris, France.
Biomolecules
|September 28, 2024
概括
长期的COVID会导致使人衰弱的症状,影响全球数百万人. 在长期COVID中,SARS-CoV-2核蛋白N可能会将病毒持续性与炎症和神经问题联系起来.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
背景情况:
- 长期的COVID-19 (长期COVID) 对全球健康造成重大负担,包括各种症状,如疲劳,厌氧和神经缺陷 (长期神经COVID).
- 心肺,胃肠道,脏和血管并发症,以及新发糖尿病,也是长期COVID的特征.
- 了解长期COVID的潜在机制,特别是神经系统的后果,仍然是一个关键的未解决的挑战.
研究的目的:
- 审查和介绍解释长期神经COVID多样性症状的主要机械学假设.
- 探索SARS-CoV-2核蛋白N作为长期COVID病变发生的中心因素的潜在作用.
主要方法:
- 这篇迷你综述综合了关于长期COVID的病理生理机制的当前研究.
- 它侧重于免疫失调,持续的病毒储存,血管功能障碍和神经递质信号干扰.
主要成果:
- 长期神经COVID的关键假设包括免疫失调,持续的病毒储存,内皮功能障碍和神经递质信号的改变.
- 建议SARS-CoV-2核蛋白N作为一个潜在的"枢纽",将病毒元素连接起来,以容纳炎症和神经反应.
结论:
- SARS-CoV-2核蛋白N可能在调解长期COVID的炎症和神经系统后果方面发挥关键作用.
- 对这些机制的进一步研究对于开发长期COVID患者的有效治疗方法至关重要.
关键词:
大脑雾是什么?大脑雾是什么?脑袋和脑袋中的一个.免疫力是一种免疫力.这是一种炎症炎症炎症炎症.长时间的COVID.线粒体功能障碍 线粒体功能障碍神经传递的神经传递它是一种核蛋白核蛋白质.物质 P 的物质 P 的物质.病毒储存库是病毒储存库.更多相关视频
00:08Non-invasive Strategies for Chronic Manipulation of DREADD-controlled Neuronal Activity
Published on: August 25, 2019
13.4K
10:45Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling
Published on: May 31, 2017
13.1K
相关概念视频
01:35Long-term Potentiation
54.9K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
54.9K
01:15Parkinson's Disease: Overview
492
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
492